To hear about similar clinical trials, please enter your email below
Trial Title:
Evaluation of Intestinal Parasites in Patients With Intestinal Cancer in Sohag, Egypt.
NCT ID:
NCT05850884
Condition:
Intestinal Parasites in Patients With Intestinal Cancer
Conditions: Official terms:
Intestinal Diseases, Parasitic
Intestinal Neoplasms
Study type:
Observational [Patient Registry]
Overall status:
Recruiting
Study design:
Time perspective:
Other
Intervention:
Intervention type:
Diagnostic Test
Intervention name:
stool examination
Description:
Each collected sample will be divided into three parts; 1st part will be examined freshly
without preservatives by macroscopic and microscopic examination, the 2nd part will be
preserved for concentration techniques, staining, and microscopic examination and the 3rd
part will be cultivated for Strongyloides stercoralis diagnosis
Arm group label:
group A
Arm group label:
group B
Summary:
This study aims to evaluate the intestinal parasitic infections in patients with
intestinal cancer in comparison to non-cancer individuals
Detailed description:
Intestinal parasitic infections continue to be characterized as a significant cause of
morbidity worldwide, and according to World Health Organization (WHO) statistics, more
than a quarter of the world's population, mostly in developing countries, are infected
Acquisition of infection, clinical severity, and outcome of a parasitic disease depend on
innate and acquired host immunity as well as on the parasite's response against the host
when the infection is established Chronic infections and inflammation along with
unhealthy diet, stressful lifestyle, cell damage, constant exposure to radiation, and
harmful chemicals are risk factors for the development of cancers As infectious factors,
the Blastocystis hominis and Cryptosporidium spp. are opportunistic protozoa isolated
from the human host gastrointestinal tract, These prevalent enteric parasites may cause
serious challenges in people undergoing colorectal cancer treatment (chemotherapy)
Criteria for eligibility:
Study pop:
Case-control study
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- intestinal cancer patients (colorectal cancer, intestinal lymphoma, gastrointestinal
stromal tumors, and other malignant variants)
Exclusion Criteria:
- patient took antibiotics within the previous four weeks and anti-parasitic drugs
within the previous two weeks
Gender:
All
Minimum age:
2 Years
Maximum age:
N/A
Locations:
Facility:
Name:
Sohag University
Address:
City:
Sohag
Country:
Egypt
Status:
Recruiting
Contact:
Last name:
nagwa i seleem, demonstrator
Phone:
01060289117
Phone ext:
002
Email:
nagwaibrahim@med.sohag.edu.eg
Start date:
November 30, 2023
Completion date:
May 30, 2024
Lead sponsor:
Agency:
Sohag University
Agency class:
Other
Source:
Sohag University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05850884
